MANAGE-VT Registry - MANAGEment of Ventricular Tachycardia Outcomes Registry

Recruiting

• Conditions: Ventricular Tachycardia
• Interventions: Procedure: Ventricular Tachycardia Ablation; Device: ICD Implant; Drug: Antiarrhythmic drug; Diagnostic Test: EKG; Diagnostic Test: Cardioversion; Diagnostic Test: Echocardiogram

• Registration Number: NCT06455488
• Lead Sponsor: CorVita Science Foundation

Brief Summary

Data collection registry for patients with ventricular tachycardia to help physicians give better care for patients clinically and procedurally.

Detailed Description

After consent from a patient the research team will input patients data from many different categories. There is a link to the PDF for the consent form, a patients anticoagulant medications will be assessed, their ventricular tachycardia (VT) history will be inputted, and their date of birth and zip code will inputted. The research team will then input any EKG's, echocardiograms, VT ablations, ICD's, S-ICD's, lab results, and comorbidities.

Study Timeline

• Study Start: 2020-07-20
• Status Verified: 2024-06
• Study First Submitted: 2024-06-05
• Study First Submitted QC: 2024-06-11
• Last Update Submitted: 2024-06-11
• Study First Posted: 2024-06-12
• Last Update Posted: 2024-06-12
• Primary Completion: 2030-07-20
• Study Completion: 2030-07-20

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 130

Inclusion Criteria

• Must be at least 18 years old
• Must not be

Exclusion Criteria

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
MANAGE-VT Patients	Ventricular Tachycardia Ablation	Patients will be assessed on the status of their ventricular tachycardia as well as other criteria such as: EKG,
MANAGE-VT Patients	Cardioversion	Patients will be assessed on the status of their ventricular tachycardia as well as other criteria such as: EKG,
MANAGE-VT Patients	ICD Implant	Patients will be assessed on the status of their ventricular tachycardia as well as other criteria such as: EKG,
MANAGE-VT Patients	EKG	Patients will be assessed on the status of their ventricular tachycardia as well as other criteria such as: EKG,
MANAGE-VT Patients	Antiarrhythmic drug	Patients will be assessed on the status of their ventricular tachycardia as well as other criteria such as: EKG,
MANAGE-VT Patients	Echocardiogram	Patients will be assessed on the status of their ventricular tachycardia as well as other criteria such as: EKG,

Primary Outcome Measures

Name	Time	Method
Number of Participants with Risk of Sudden Cardiac Death	July 20, 2020 - Present	All events of sudden cardiac death that arise from patients with ventricular tachycardia
Recurrence of Ventricular Tachycardia	July 20, 2020 - Present	The natural progression of v-tach will be assessed through medical record review
Prevent Risk of Stroke	July 20, 2020 - Present	All strokes, transient ischemic and systemic thrombo-embolic events

Trial Locations

Locations (1)

Corvita Science Foundation; 🇺🇸 Chicago, Illinois, United States